Periodical
View in EDS

Merck KGaA Secures $11.3 Billion Purchase of Bio-Techne.

Bibliographic Details
Title: Merck KGaA Secures $11.3 Billion Purchase of Bio-Techne.
Authors: Wind, Sonja (AUTHOR)
Source: Bloomberg.com. 6/25/2026, pN.PAG-N.PAG. 1p.
Subject Terms: *Mergers & acquisitions, *Sales statistics, *Diagnostic services, *Economic efficiency, *Pharmaceutical industry, Life sciences, Scientific apparatus & instruments
Company/Entity: Merck KGaA
Abstract: The article focuses on Merck KGaA's agreement to acquire Bio-Techne Corporation for approximately $11.3 billion to strengthen its life-science division. Merck, a German pharmaceutical and technology company, will pay $73 per share in cash, representing a 24% premium on Bio-Techne's recent closing price. Bio-Techne, a US-based diagnostics firm, provides research tools including lab-made proteins and antibodies, which Merck aims to integrate with its own products to offer a broader range of life-science solutions. The acquisition, Merck's largest since 2014, is expected to enhance sales growth, earnings margins, and generate significant cost synergies within three years. [Extracted from the article]
Copyright of Bloomberg.com is the property of Bloomberg, L.P. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Business Source Index
FullText Text:
  Availability: 0
Header DbId: bsx
DbLabel: Business Source Index
An: 194872017
RelevancyScore: 1430
AccessLevel: 6
PubType: Periodical
PubTypeId: serialPeriodical
PreciseRelevancyScore: 1430
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Merck KGaA Secures $11.3 Billion Purchase of Bio-Techne.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Wind%2C+Sonja%22">Wind, Sonja</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Bloomberg%2Ecom%22">Bloomberg.com</searchLink>. 6/25/2026, pN.PAG-N.PAG. 1p.
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: *<searchLink fieldCode="DE" term="%22Mergers+%26+acquisitions%22">Mergers & acquisitions</searchLink><br />*<searchLink fieldCode="DE" term="%22Sales+statistics%22">Sales statistics</searchLink><br />*<searchLink fieldCode="DE" term="%22Diagnostic+services%22">Diagnostic services</searchLink><br />*<searchLink fieldCode="DE" term="%22Economic+efficiency%22">Economic efficiency</searchLink><br />*<searchLink fieldCode="DE" term="%22Pharmaceutical+industry%22">Pharmaceutical industry</searchLink><br /><searchLink fieldCode="DE" term="%22Life+sciences%22">Life sciences</searchLink><br /><searchLink fieldCode="DE" term="%22Scientific+apparatus+%26+instruments%22">Scientific apparatus & instruments</searchLink>
– Name: SubjectCompany
  Label: Company/Entity
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Merck+KGaA%22">Merck KGaA</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: The article focuses on Merck KGaA's agreement to acquire Bio-Techne Corporation for approximately $11.3 billion to strengthen its life-science division. Merck, a German pharmaceutical and technology company, will pay $73 per share in cash, representing a 24% premium on Bio-Techne's recent closing price. Bio-Techne, a US-based diagnostics firm, provides research tools including lab-made proteins and antibodies, which Merck aims to integrate with its own products to offer a broader range of life-science solutions. The acquisition, Merck's largest since 2014, is expected to enhance sales growth, earnings margins, and generate significant cost synergies within three years. [Extracted from the article]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Bloomberg.com is the property of Bloomberg, L.P. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=bsx&AN=194872017
RecordInfo BibRecord:
  BibEntity:
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: N.PAG
    Subjects:
      – SubjectFull: Mergers & acquisitions
        Type: general
      – SubjectFull: Sales statistics
        Type: general
      – SubjectFull: Diagnostic services
        Type: general
      – SubjectFull: Economic efficiency
        Type: general
      – SubjectFull: Pharmaceutical industry
        Type: general
      – SubjectFull: Life sciences
        Type: general
      – SubjectFull: Scientific apparatus & instruments
        Type: general
      – SubjectFull: Merck KGaA
        Type: general
    Titles:
      – TitleFull: Merck KGaA Secures $11.3 Billion Purchase of Bio-Techne.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wind, Sonja
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 25
              M: 06
              Text: 6/25/2026
              Type: published
              Y: 2026
          Titles:
            – TitleFull: Bloomberg.com
              Type: main
ResultId 1